Your browser doesn't support javascript.
loading
Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants.
Xu, Haiyan; Zhang, Quan; Liang, Li; Li, Junling; Liu, Zhefeng; Li, Weihua; Yang, Lu; Yang, Guangjian; Xu, Fei; Ying, Jianming; Zhang, Shucai; Wang, Yan.
Afiliação
  • Xu H; Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Zhang Q; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Liang L; Cancer Chemotherapy and Radiation Department, Peking University Third Hospital, Beijing, China.
  • Li J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Liu Z; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China.
  • Li W; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Yang L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Yang G; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Xu F; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Ying J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Zhang S; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Wang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Cancer Med ; 9(10): 3328-3336, 2020 05.
Article em En | MEDLINE | ID: mdl-32168429
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas Tirosina Quinases / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Adenocarcinoma de Pulmão / Crizotinibe / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas Tirosina Quinases / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Adenocarcinoma de Pulmão / Crizotinibe / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos